Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice

Frontiers in Neuroscience

Volumn , Issue 8 MAY, 2014, Pages

  Blednov, Yuri A ^a   Benavidez, Jillian M ^a   Black, Mendy ^a   Adron Harris, R ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Alcohol; CDP840; Mesopram; PDE inhibitors; Piclamilast; Rolipram; Two bottle choice

Indexed keywords

4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE; DAXALIPRAM; LOPRINONE; MILRINONE; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; PICLAMILAST; PROPENTOFYLLINE; ROLIPRAM; VINPOCETINE; ZAPRINAST;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; ENZYME INHIBITION; FLUID INTAKE; MALE; MOUSE; NONHUMAN;

EID: 84905018238     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00129     Document Type: Article

References (62)

1. Ashton, M. J., Cook, D. C., Fenton, G., Karlsson, J. A., Palfreyman, M. N., Raeburn, D., et al. (1994). Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analogues. J. Med. Chem. 37, 1696-1703. doi: 10.1021/jm00037a021
2. Bell, R. L., Lopez, M. F., Cui, C., Egli, M., Johnson, K. W., Franklin, K. M., et al. (2013). Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. Addict. Biol. doi: 10.1111/adb.12106. [Epub ahead of print].
3. Bender, A. T., and Beavo, J. A. (2006). Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58, 488-520. doi: 10.1124/pr.58.3.5
4. Blednov, Y. A., Benavidez, J. M., Geil, C., Perra, S., Morikawa, H., and Harris, R. A. (2011). Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice. Brain Behav. Immun. 25(Suppl. 1), S92-S105. doi: 10.1016/j.bbi.2011.01.008
5. Blednov, Y. A., Bergeson, S. E., Walker, D., Ferreira, V. M., Kuziel, W. A., and Harris, R. A. (2005). Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol. Behav. Brain Res. 165, 110-125. doi: 10.1016/j.bbr.2005.06.026
6. Blednov, Y. A., and Harris, R. A. (2008). Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. Int. J. Neuropsychopharmacol. 11, 775-793. doi: 10.1017/S1461145708008584
7. Blednov, Y. A., Ponomarev, I., Geil, C., Bergeson, S., Koob, G. F., and Harris, R. A. (2012). Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict. Biol. 17, 108-120. doi: 10.1111/j.1369-1600.2010.00284.x
8. Blednov, Y. A., Stoffel, M., Chang, S. R., and Harris, R. A. (2001). Potassium channels as targets for ethanol: studies of G-protein-coupled inwardly rectifying potassium channel 2 (GIRK2) null mutant mice. J. Pharmacol. Exp. Ther. 298, 521-530.
9. Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., and Brewer, R. D. (2011). Economic costs of excessive alcohol consumption in the U.S., 2006. Am. J. Prev. Med. 41, 516-524. doi: 10.1016/j.amepre.2011.06.045
10. Bouza, C., Angeles, M., Munoz, A., and Amate, J. M. (2004). Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99, 811-828. doi: 10.1111/j.1360-0443.2004.00763.x
11. Buttini, M., Mir, A., Appel, K., Wiederhold, K. H., Limonta, S., Gebicke-Haerter, P. J., et al. (1997). Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram. Br. J. Pharmacol. 122, 1483-1489. doi: 10.1038/sj.bjp.0701502
12. Cherry, J. A., and Davis, R. L. (1999). Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J. Comp. Neurol. 407, 287-301.
13. Crabbe, J. C., Harris, R. A., and Koob, G. F. (2011). Preclinical studies of alcohol binge drinking. Ann. N.Y. Acad. Sci. 1216, 24-40. doi: 10.1111/j.1749-6632.2010.05895.x
14. Crews, F. T. (2012). Immune function genes, genetics, and the neurobiology of addiction. Alcohol Res. 34, 355-361.
15. Dinter, H., Tse, J., Halks-Miller, M., Asarnow, D., Onuffer, J., Faulds, D., et al. (2000). The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. J. Neuroimmunol. 108, 136-146. doi: 10.1016/S0165-5728(00)00265-4
16. Di Paola, R., Mazzon, E., Paterniti, I., Impellizzeri, D., Bramanti, P., and Cuzzocrea, S. (2011). Olprinone, a PDE3 inhibitor, modulates the inflammation associated with myocardial ischemia-reperfusion injury in rats. Eur. J. Pharmacol. 650, 612-620. doi: 10.1016/j.ejphar.2010.10.043
17. Duplantier, A. J., Biggers, M. S., Chambers, R. J., Cheng, J. B., Cooper, K., Damon, D. B., et al. (1996). Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret. J. Med. Chem. 39, 120-125. doi: 10.1021/jm9505066
18. Flatscher-Bader, T., Zuvela, N., Landis, N., and Wilce, P. A. (2008). Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area. Hum. Mol. Genet. 17, 38-51. doi: 10.1093/hmg/ddm283
19. Forget, M. A., Sisson, J. H., Spurzem, J. R., and Wyatt, T. A. (2003). Ethanol increases phosphodiesterase 4 activity in bovine bronchial epithelial cells. Alcohol 31, 31-38. doi: 10.1016/j.alcohol.2003.06.005
20. Genovese, T., Mazzon, E., Paterniti, I., Esposito, E., and Cuzzocrea, S. (2011). Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats. Neurosci. Lett. 503, 93-99. doi: 10.1016/j.neulet.2011.08.015
21. Ghosh, M., Garcia-Castillo, D., Aguirre, V., Golshani, R., Atkins, C. M., Bramlett, H. M., et al. (2012). Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury. Glia 60, 1839-1859. doi: 10.1002/glia.22401
22. Giembycz, M. A. (2008). Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking? Br. J. Pharmacol. 155, 288-290. doi: 10.1038/bjp.2008.297
23. Halene, T. B., and Siegel, S. J. (2007). PDE inhibitors in psychiatry-future options for dementia, depression and schizophrenia? Drug Discov. Today 12, 870-878. doi: 10.1016/j.drudis.2007.07.023
24. Harris, R. A., and Blednov, Y. A. (2013). "Neuroimmune genes and alcohol drinking behavior," in Neural-Immune Interactions in Brain Function and Alcohol Related Disorders, eds C. Cui, L. Grandison, and A. Noronha (New York, NY: Springer Science+Business Media), 425-440.
25. He, J., and Crews, F. T. (2008). Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 210, 349-358. doi: 10.1016/j.expneurol.2007.11.017
26. Heilig, M., and Egli, M. (2006). Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 111, 855-876. doi: 10.1016/j.pharmthera.2006.02.001
27. Hirose, R., Manabe, H., Nonaka, H., Yanagawa, K., Akuta, K., Sato, S., et al. (2007). Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain. Eur. J. Pharmacol. 573, 93-99. doi: 10.1016/j.ejphar.2007.06.045
28. Hotte, M., Dauphin, F., Freret, T., Boulouard, M., and Levallet, G. (2012). A biphasic and brain-region selective down-regulation of cyclic adenosine monophosphate concentrations supports object recognition in the rat. PLoS ONE 7:e32244. doi: 10.1371/journal.pone.0032244
29. Hu, W., Lu, T., Chen, A., Huang, Y., Hansen, R., Chandler, L. J., et al. (2011). Inhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology (Berl). 218, 331-339. doi: 10.1007/s00213-011-2290-8
30. Jin, S. L., Ding, S. L., and Lin, S. C. (2012). Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Chang Gung Med. J. 35, 197-210.
31. Johnson, B. A., Rosenthal, N., Capece, J. A., Wiegand, F., Mao, L., Beyers, K., et al. (2007). Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298, 1641-1651. doi: 10.1001/jama.298.14.1641
32. Johnson, C., Drgon, T., Liu, Q. R., Walther, D., Edenberg, H., Rice, J., et al. (2006). Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 844-853. doi: 10.1002/ajmg.b.30346
33. Kanes, S. J., Tokarczyk, J., Siegel, S. J., Bilker, W., Abel, T., and Kelly, M. P. (2007). Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. Neuroscience 144, 239-246. doi: 10.1016/j.neuroscience.2006.09.026
34. Keravis, T., and Lugnier, C. (2012). Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. Br. J. Pharmacol. 165, 1288-1305. doi: 10.1111/j.1476-5381.2011.01729.x
35. Kim, K. S., Kim, H., Baek, I. S., Lee, K. W., and Han, P. L. (2011). Mice lacking adenylyl cyclase type 5 (AC5) show increased ethanol consumption and reduced ethanol sensitivity. Psychopharmacology (Berl). 215, 391-398. doi: 10.1007/s00213-010-2143-x
36. Kimpel, M. W., Strother, W. N., McClintick, J. N., Carr, L. G., Liang, T., Edenberg, H. J., et al. (2007). Functional gene expression differences between inbred alcohol-preferring and -non-preferring rats in five brain regions. Alcohol 41, 95-132. doi: 10.1016/j.alcohol.2007.03.003
37. Knapp, C. M., Foye, M. M., Ciraulo, D. A., and Kornetsky, C. (1999). The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol. Biochem. Behav. 62, 151-158. doi: 10.1016/S0091-3057(98)00154-3
38. Liu, J., Lewohl, J. M., Harris, R. A., Dodd, P. R., and Mayfield, R. D. (2007). Altered gene expression profiles in the frontal cortex of cirrhotic alcoholics. Alcohol. Clin. Exp. Res. 31, 1460-1466. doi: 10.1111/j.1530-0277.2007.00444.x
39. Liu, J., Lewohl, J. M., Harris, R. A., Iyer, V. R., Dodd, P. R., Randall, P. K., et al. (2006). Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology 31, 1574-1582. doi: 10.1038/sj.npp.1300947
40. Maas, J. W. Jr., Vogt, S. K., Chan, G. C., Pineda, V. V., Storm, D. R., and Muglia, L. J. (2005). Calcium-stimulated adenylyl cyclases are critical modulators of neuronal ethanol sensitivity. J. Neurosci. 25, 4118-4126. doi: 10.1523/JNEUROSCI.4273-04.2005
41. Mayfield, J., Ferguson, L., and Harris, R. A. (2013). Neuroimmune signaling: a key component of alcohol abuse. Curr. Opin. Neurobiol. 23, 513-520. doi: 10.1016/j.conb.2013.01.024
42. Meskini, N., Nemoz, G., Okyayuz-Baklouti, I., Lagarde, M., and Prigent, A. F. (1994). Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem. Pharmacol. 47, 781-788. doi: 10.1016/0006-2952(94)90477-4
43. Mulligan, M. K., Ponomarev, I., Hitzemann, R. J., Belknap, J. K., Tabakoff, B., Harris, R. A., et al. (2006). Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis. Proc. Natl. Acad. Sci. U.S.A. 103, 6368-6373. doi: 10.1073/pnas.0510188103
44. Nunes, F., Ferreira-Rosa, K., Pereira Mdos, S., Kubrusly, R. C., Manhaes, A. C., Abreu-Villaca, Y., et al. (2011). Acute administration of vinpocetine, a phosphodiesterase type 1 inhibitor, ameliorates hyperactivity in a mice model of fetal alcohol spectrum disorder. Drug Alcohol Depend. 119, 81-87. doi: 10.1016/j.drugalcdep.2011.05.024
45. Osterndorff-Kahanek, E., Ponomarev, I., Blednov, Y. A., and Harris, R. A. (2013). Gene expression in brain and liver produced by three different regimens of alcohol consumption in mice: comparison with immune activation. PLoS ONE 8:e59870. doi: 10.1371/journal.pone.0059870
46. Page, C. P., and Spina, D. (2011). Phosphodiesterase inhibitors in the treatment of inflammatory diseases. Handb. Exp. Pharmacol. 391-414. doi: 10.1007/978-3-642-17969-3_17
47. Perry, M. J., O'Connell, J., Walker, C., Crabbe, T., Baldock, D., Russell, A., et al. (1998). CDP840: a novel inhibitor of PDE-4. Cell Biochem. Biophys. 29, 113-132. doi: 10.1007/BF02737831
48. Prickaerts, J., Sik, A., Van Staveren, W. C., Koopmans, G., Steinbusch, H. W., Van Der Staay, F. J., et al. (2004). Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem. Int. 45, 915-928. doi: 10.1016/j.neuint.2004.03.022
49. Qin, L., He, J., Hanes, R. N., Pluzarev, O., Hong, J. S., and Crews, F. T. (2008). Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J. Neuroinflammation 5, 10. doi: 10.1186/1742-2094-5-10
50. Raeburn, D., and Karlsson, J. A. (1993). Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. J. Pharmacol. Exp. Ther. 267, 1147-1152.
51. Rhodes, J. S., Best, K., Belknap, J. K., Finn, D. A., and Crabbe, J. C. (2005). Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol. Behav. 84, 53-63. doi: 10.1016/j.physbeh.2004.10.007
52. Saklani, R., Jaggi, A., and Singh, N. (2010). Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. Arch. Pharm. Res. 33, 1049-1057. doi: 10.1007/s12272-010-0711-6
53. Schneider, H. H., Schmiechen, R., Brezinski, M., and Seidler, J. (1986). Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur. J. Pharmacol. 127, 105-115. doi: 10.1016/0014-2999(86)90210-4
54. Shahid, M., Van Amsterdam, R. G., De Boer, J., Ten Berge, R. E., Nicholson, C. D., and Zaagsma, J. (1991). The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. Br. J. Pharmacol. 104, 471-477. doi: 10.1111/j.1476-5381.1991.tb12453.x
55. Smith, D. L., Pozueta, J., Gong, B., Arancio, O., and Shelanski, M. (2009). Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc. Natl. Acad. Sci. U.S.A. 106, 16877-16882. doi: 10.1073/pnas.0908706106
56. Sugioka, M., Ito, M., Masuoka, H., Ichikawa, K., Konishi, T., Tanaka, T., et al. (1994). Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes. Naunyn Schmiedebergs Arch. Pharmacol. 350, 284-293. doi: 10.1007/BF00175034
57. Thompson, B. E., Sachs, B. D., Kantak, K. M., and Cherry, J. A. (2004). The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice. Eur. J. Neurosci. 19, 2561-2568. doi: 10.1111/j.0953-816X.2004.03357.x
58. Wen, R. T., Zhang, M., Qin, W. J., Liu, Q., Wang, W. P., Lawrence, A. J., et al. (2012). The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol. Clin. Exp. Res. 36, 2157-2167. doi: 10.1111/j.1530-0277.2012.01845.x
59. Xiao, L., O'Callaghan, J. P., and O'Donnell, J. M. (2011). Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation, and behavior in the forced-swim test. J. Pharmacol. Exp. Ther. 338, 641-647. doi: 10.1124/jpet.111.179358
60. Yamada, K., Tanaka, T., Senzaki, K., Kameyama, T., and Nabeshima, T. (1998). Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40). Eur. J. Pharmacol. 349, 15-22. doi: 10.1016/S0014-2999(98)00166-6
61. Yoshikawa, M., Suzumura, A., Tamaru, T., Takayanagi, T., and Sawada, M. (1999). Effects of phosphodiesterase inhibitors on cytokine production by microglia. Mult. Scler. 5, 126-133. doi: 10.1177/135245859900500210
62. Zhu, J., Mix, E., and Winblad, B. (2001). The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev. 7, 387-398. doi: 10.1111/j.1527-3458.2001.tb00206.x